Natco Pharma

Natco commences phase-III clinical trial of Molnupiravir for COVID-19 treatment

Read more

Government working to eliminate shortage of Amphotericin-B drug: Mansukh Mandaviya

Read more

Lilly signs voluntary licensing agreement with Natco for baricitinib

Read more

NATCO receives emergency-use approval for Baricitinib tablets for COVID-19 treatment

Read more

NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19

Read more

NATCO gets tentative US FDA approval for Ibrutinib tablets

Read more

Natco Pharma board okays acquiring 1 per cent in Canadian arm

Read more

NATCO ventures into Pheromone based tech for Integrated Pest Management

Read more

NATCO gets US FDA nod for Everolimus tablets  

Read more

NATCO launches Brivaracetam tablets in India

Read more